Bottom line
JAMCX vs IJMAX: the short answer
JAMCX (JPMorgan Mid Cap Value Fund) and IJMAX (VY(R) JPMorgan Mid Cap Value Portfolio) are both mutual funds.
JAMCX is cheaper at 1.04% vs 1.35% — a difference of $31 a year per $10,000 invested.
Over five years, IJMAX returned +9.0% a year vs +8.2% for JAMCX.
JAMCX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
JAMCX vs IJMAX side by side
| JAMCX | IJMAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | J.P. Morgan | J.P. Morgan |
| Category | Mid-Cap | Mid-Cap |
| Expense ratio | 1.04% | 1.35% |
| Annual cost per $10k | $104 | $135 |
| 10-yr cost on $10k (prospectus) | $1,880 | $1,879 |
| Max front load | 5.25% | — |
| 12b-1 fee | 0.25% | 0.5% |
| 1-yr return | −0.9% | +4.1% |
| 5-yr return (annualized) | +8.2% | +9.0% |
| 10-yr return (annualized) | +7.8% | +8.2% |
| Best quarter | +19.2% | +19.6% |
| Worst quarter | −31.9% | −31.9% |
| Net assets (fund) | $11.2B | $189.1M |
| Number of holdings | 105 | 106 |
| Portfolio turnover | 68% | 47% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JAMCX | IJMAX | Difference |
|---|---|---|---|
| 2025 | +4.6% | +4.1% | +0.5% |
| 2024 | +13.8% | +13.7% | +0.1% |
| 2023 | +10.9% | +10.3% | +0.6% |
| 2022 | −8.5% | −8.8% | +0.4% |
| 2021 | +29.5% | +29.2% | +0.3% |
| 2020 | −0.1% | +0.1% | −0.2% |
| 2019 | +26.0% | +25.8% | +0.2% |
| 2018 | −12.1% | −12.4% | +0.3% |
| 2017 | +13.1% | +13.4% | −0.3% |
| 2016 | +14.1% | +14.4% | −0.4% |
Source: Fund prospectus bar charts
Holdings overlap
24 of JAMCX's top 25 holdings also appear in IJMAX's top 25.
| Holding | JAMCX | IJMAX |
|---|---|---|
| IQVIA Holdings, Inc. | 2.31% | 2.29% |
| MKS, Inc. | 2.16% | 2.15% |
| Silgan Holdings, Inc. | 1.76% | 1.75% |
| Healthpeak Properties, Inc. | 1.73% | 1.72% |
| AMETEK, Inc. | 1.71% | 1.69% |
| Ameriprise Financial, Inc. | 1.61% | 1.60% |
| M&T Bank Corp. | 1.60% | 1.59% |
| First Citizens BancShares, Inc. | 1.52% | 1.51% |
| Omnicom Group, Inc. | 1.50% | 1.49% |
| Quest Diagnostics, Inc. | 1.49% | 1.48% |
| Dover Corp. | 1.49% | 1.48% |
| CDW Corp. | 1.44% | 1.43% |
| Loews Corp. | 1.41% | 1.40% |
| Middleby Corp. (The) | 1.37% | 1.36% |
| Fidelity National Information Services, Inc. | 1.35% | 1.62% |
Source: SEC Form N-PORT
JAMCX top 10
- JPMorgan Prime Money Market Fund — 4.26%
- IQVIA Holdings, Inc. — 2.31%
- MKS, Inc. — 2.16%
- Silgan Holdings, Inc. — 1.76%
- Healthpeak Properties, Inc. — 1.73%
- AMETEK, Inc. — 1.71%
- Ameriprise Financial, Inc. — 1.61%
- M&T Bank Corp. — 1.60%
- First Citizens BancShares, Inc. — 1.52%
- Omnicom Group, Inc. — 1.50%
IJMAX top 10
- Blackrock Liquidity Funds — 3.97%
- Iqvia Holdings Inc — 2.29%
- Mks Inc — 2.15%
- Silgan Holdings Inc — 1.75%
- Healthpeak Properties Inc — 1.72%
- Ametek Inc — 1.69%
- Fidelity National Information Services Inc — 1.62%
- Ameriprise Financial Inc — 1.60%
- M&t Bank Corp — 1.59%
- Ge Healthcare Technologies Inc — 1.56%
FAQ
What is the difference between JAMCX and IJMAX?
Which is cheaper, JAMCX or IJMAX?
Should I own both JAMCX and IJMAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.